US 11,837,106 B2
System and method to monitor and titrate treatment for high altitude-induced central sleep apnea (CSA)
Benjamin Irwin Shelly, Pittsburgh, PA (US)
Assigned to KONINKLIJKE PHILIPS N.V., Eindhoven (NL)
Filed by KONINKLIJKE PHILIPS N.V., Eindhoven (NL)
Filed on Nov. 30, 2020, as Appl. No. 17/106,827.
Claims priority of provisional application 63/054,197, filed on Jul. 20, 2020.
Prior Publication US 2022/0020501 A1, Jan. 20, 2022
Int. Cl. G09B 19/00 (2006.01); G16H 20/60 (2018.01); A61B 5/0205 (2006.01); A61B 5/0531 (2021.01); A61B 5/16 (2006.01); A61B 5/00 (2006.01); A61K 31/4045 (2006.01); G16H 50/50 (2018.01); A61B 5/08 (2006.01); A61B 5/1455 (2006.01); A61M 16/00 (2006.01); G16H 40/67 (2018.01); G16H 10/60 (2018.01); G16H 50/30 (2018.01); G16H 50/70 (2018.01); G16H 50/20 (2018.01); G06N 3/08 (2023.01); G16H 20/10 (2018.01); G16H 10/20 (2018.01); G16H 20/00 (2018.01); G06N 20/00 (2019.01); G16H 20/30 (2018.01); G06N 5/02 (2023.01); A61B 5/024 (2006.01); A61B 5/11 (2006.01)
CPC G09B 19/00 (2013.01) [A61B 5/0205 (2013.01); A61B 5/0531 (2013.01); A61B 5/0806 (2013.01); A61B 5/14551 (2013.01); A61B 5/165 (2013.01); A61B 5/486 (2013.01); A61B 5/4815 (2013.01); A61B 5/4818 (2013.01); A61B 5/4836 (2013.01); A61B 5/4839 (2013.01); A61B 5/4842 (2013.01); A61B 5/4848 (2013.01); A61B 5/7267 (2013.01); A61B 5/7275 (2013.01); A61B 5/7475 (2013.01); A61K 31/4045 (2013.01); A61M 16/0003 (2014.02); A61M 16/024 (2017.08); A61M 16/026 (2017.08); G06N 3/08 (2013.01); G06N 5/02 (2013.01); G06N 20/00 (2019.01); G16H 10/20 (2018.01); G16H 10/60 (2018.01); G16H 20/00 (2018.01); G16H 20/10 (2018.01); G16H 20/30 (2018.01); G16H 20/60 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); G16H 50/50 (2018.01); G16H 50/70 (2018.01); A61B 5/02405 (2013.01); A61B 5/1118 (2013.01); A61B 5/4806 (2013.01); A61B 2560/0242 (2013.01); A61B 2560/0257 (2013.01); A61B 2562/0219 (2013.01); A61M 2205/3303 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/502 (2013.01)] 12 Claims
OG exemplary drawing
 
1. A method of automatically and dynamically titrating treatment for altitude-induced Central Sleep Apnea (CSA) for a person using a wearable device structured to be worn on a body of the person and having a processor apparatus, comprising:
for each of a number of periods of sleep of the person, determining in the wearable device a number of Sleep-Disordered Breathing (SDB) severity values, each SDB severity value of the number of SDB severity values being based at least in part upon a corresponding effective altitude value and a corresponding dosage of a CSA treatment;
automatically determining in the wearable device a current effective altitude of the person;
determining in the wearable device based at least in part upon at least a subset of the number of Sleep-Disordered Breathing (SDB) severity values and the current effective altitude, a preferred dosage of the CSA treatment at which a likely SDB severity value is no greater than a predetermined SDB severity value; and
generating an output from the wearable device indicating a recommended treatment for CSA at the preferred dosage of the CSA treatment.